Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000805928-25-000002
Filing Date
2025-01-06
Accepted
2025-01-06 18:39:06
Documents
1
Period of Report
2025-01-06

Document Format Files

Seq Description Document Type Size
1 FORM 4 wk-form4_1736206734.html 4  
1 FORM 4 wk-form4_1736206734.xml 4 3789
  Complete submission text file 0000805928-25-000002.txt   5492
Mailing Address 13631 PROGRESS BLVD. SUITE 400 ALACHUA FL 32615
Business Address 13631 PROGRESS BLVD. SUITE 400 ALACHUA FL 32615 (386) 462-6817
Axogen, Inc. (Issuer) CIK: 0000805928 (see all company filings)

EIN.: 411301878 | State of Incorp.: MN | Fiscal Year End: 1231
SIC: 3845 Electromedical & Electrotherapeutic Apparatus
(CF Office: 08 Industrial Applications and Services)

Mailing Address BRAINSTORM CELL THERAPEUTICS, INC. 1325 AVENUE OF AMERICAS, 28TH FLOOR NEW YORK NY 10019
Business Address
Naor Nir (Reporting) CIK: 0001982278 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36046 | Film No.: 25512846